Maadhav Deekshitha

20 posts

Maadhav Deekshitha

Maadhav Deekshitha

@MaadhavD2

Co-founder & CTO @TryEnjamb (YC P26)

Katılım Nisan 2026
22 Takip Edilen28 Takipçiler
Sabitlenmiş Tweet
Maadhav Deekshitha
Maadhav Deekshitha@MaadhavD2·
hi I'm Maadhav, I'm the youngest founder in the current YC batch (P26) here's a bit about me: at 15 I joined Dell's AI Lab, working on the best supercomputers in the world at 16 I was poached by Broadcom R&D to develop AI chips now I'm backed by YC and building Cursor for Biopharma R&D
Maadhav Deekshitha tweet media
English
5
2
15
3.3K
Maadhav Deekshitha
Maadhav Deekshitha@MaadhavD2·
The future of AI is scientific discovery. What Codex and modern coding tools brought to developers, we’re bringing to scientific research at @tryenjamb.
Rayan Mubarak@rayannmubarak

Today @sama revealed to YC @OpenAI’s future for scientific discovery. Open AI’s mission is to create the best scientific model. At Enjamb our mission is to create the best scientific platform and harness for those models.

English
0
0
0
6
Linyan Fu
Linyan Fu@Linyan_Fu·
New store. New aisles. New orders. Same robot doing what it does best — picking live @Instacart orders. Building in @fdotinc
English
5
7
68
4.2K
Maadhav Deekshitha retweetledi
Maadhav Deekshitha
Maadhav Deekshitha@MaadhavD2·
hi I'm Maadhav, I'm the youngest founder in the current YC batch (P26) here's a bit about me: at 15 I joined Dell's AI Lab, working on the best supercomputers in the world at 16 I was poached by Broadcom R&D to develop AI chips now I'm backed by YC and building Cursor for Biopharma R&D
Maadhav Deekshitha tweet media
English
5
2
15
3.3K
Maadhav Deekshitha retweetledi
Rayan Mubarak
Rayan Mubarak@rayannmubarak·
@SrushtiMad Hi Srushti, I started researching pesticide poisoning after my aunt, who was a rice farmer, passed away from it. I was desperate to help out and wanted to use my passion for science to make sure no one else would ever have to face a similar situation.
English
1
1
3
173
Rayan Mubarak
Rayan Mubarak@rayannmubarak·
hi, It's been a while since I've introduced myself I'm Rayan. at 15, I was the youngest ever in my lab working on therapeutics for pesticide poisoning at 16, I presented my research at the #1 neuro tox conference at 17, I built the best ML framework for lung cancer immunotherapy biomarker detection (20% better than industry standard) now I'm YC backed and building Cursor for biopharma R&D
English
16
0
69
4.2K
John Cumbers
John Cumbers@johncumbers·
A year of planning. Thousands of emails. More calls than I can count. We're finally here. The team is on the floor at the San Jose Convention Center setting up for #SynBioBeta2026, and it's hitting me just how much has gone into this. The speakers, the sessions, the conversations that are about to happen, this is what we've been building toward. If you don't have your ticket yet, now is the time. The people in this room over the next few days are going to shape where synthetic biology goes next. You don't want to watch that from the sidelines. @SynBioBeta is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: syntheticbiologysummit.com/?utm_source=X&…
John Cumbers tweet mediaJohn Cumbers tweet mediaJohn Cumbers tweet mediaJohn Cumbers tweet media
English
2
3
21
810
Maadhav Deekshitha
Maadhav Deekshitha@MaadhavD2·
It costs $2.6 billion and 10+ years to ship a single drug. Most of that timeline isn't bench science. It's the workflows around it: literature, asset diligence, protocol design, data analysis, regulatory submissions, ELN. Each one is broken in a specific way.
English
0
1
2
70
Rayan Mubarak
Rayan Mubarak@rayannmubarak·
I built Enjamb It's Cursor for Research. In the web and collaborative. It has Word, PPT, Excel, Latex built in and agent controllable, kinda like having a PhD next to you. I've been using it the past few days to automate the boring stuff, 10/10
English
6
4
28
2.7K
Rayan Mubarak
Rayan Mubarak@rayannmubarak·
We are still years off from fully autonomous AI life science labs. I think the reality of AI in bio is more similar to what Claude Code did for developers.
Ginkgo Bioworks@Ginkgo

We worked with @OpenAI to connect AI to our autonomous lab. Read all about it in a new article from @AIMmediahouse: 🟢 How AI models designed experiments, generated protocols, and analyzed results from lab runs on Nebula, our autonomous lab 🟢 Results that improved cell-free protein synthesis #CFPS costs by 40% over the state-of-the-art 🟢 Shoutouts from @joyjiao12 and Yunyun Wang on the OpenAI Podcast hubs.la/Q04dn0QR0

English
1
0
1
114
Maadhav Deekshitha retweetledi
Rayan Mubarak
Rayan Mubarak@rayannmubarak·
Excited to share Enjamb Labs is joining Y Combinator. We're building Claude Co-work for Collaborative Research. Science today is fragmented across 10 different legacy tools. Research has never had its IDE. Maadhav and I are building it.
Rayan Mubarak tweet media
English
21
3
44
3.4K
Maadhav Deekshitha retweetledi
Rayan Mubarak
Rayan Mubarak@rayannmubarak·
i just built the best agent for writing word docs. enjamb v2 is going to change research forever. Enjamb output:
Rayan Mubarak tweet media
English
1
2
6
262
Maadhav Deekshitha retweetledi
Paul Kohlhaas bio/acc
Paul Kohlhaas bio/acc@paulkhls·
🧵 Over 24 hours, our scientific team and AI scientist infrastructure developed a novel peptide agonist to potentially treat ADHD. Below is our paper for a pre-IND computational feasibility assessment for OX2R-004: an 18-residue peptide agonist designed as a selective OX2R agonist for ADHD. Why this matters? No approved orexin agonists exist anywhere. All marketed orexin drugs are dual OX1R/OX2R antagonists for insomnia. Clinical-stage ones are small molecules for narcolepsy only. We did this with @peptai_ a novel full 8-gate computational pipeline in one shot developed by @BioProtocol community 👇
Paul Kohlhaas bio/acc tweet media
English
63
99
815
740.5K